PDF(1180 KB)
RT-PCR-DGGE检测急性白血病儿童胸苷酸合成酶基因多态性研究
陈小文, 岳丽杰, 李长钢, 李成荣, 张民, 石红松
中国当代儿科杂志 ›› 2009, Vol. 11 ›› Issue (04) : 251-254.
PDF(1180 KB)
PDF(1180 KB)
RT-PCR-DGGE检测急性白血病儿童胸苷酸合成酶基因多态性研究
Polymorphisms of thymidylate synthase gene detected by RT-PCR-denaturing gradient gel electrophoresis in children with acute leukemia
目的：胸苷酸合成酶(TS)是DNA合成的关键酶，在DNA合成与修复中起重要作用，是叶酸代谢循环中起中心作用的酶类之一，也是以5-氟尿嘧啶（5-FU）为基础化疗的靶酶，TS的遗传多态性在抗白血病等肿瘤疾病5-FU类药物的体内代谢中起着重要作用。该文研究胸苷酸合成酶基因编码区单核苷酸多态性（cSNP）及基因突变在急性白血病（AL）患儿和正常儿童中的分布情况，以探讨TS基因变异与AL患儿5-FU类药物化疗效应之间可能的相关性。方法：应用RT-PCR-变性梯度凝胶电泳（RT-PCR-DGGE）结合DNA直接测序技术，对53例AL患儿和115例正常儿童的cDNAs进行了TS 基因cSNP及基因突变的筛查与鉴定，分析各基因型在两组之间的分布差异。结果：首次鉴定了儿童TS 381 A＞G (E127E) cSNP位点，其在AL患儿及正常儿童中的等位基因频率分别为12.3%，13.5%，与国际SNP文库中12.3%基本一致。该cSNP在两组人群的等位基因频率差异无显著性意义，与白血病的易感性无相关性。研究未发现T349C, G470T及C500T变异。结论：采用RTPCR-DGGE结合DNA测序法首次确定了儿童TS基因存在381 A＞G cSNP位点，其等位基因频率为13.1%，基因型分布频率在AL患儿及正常儿童两组人群中差异无显著性。［中国当代儿科杂志，2009，11（4）：251-254］
OBJECTIVE: Thymidylate synthase (TS) catalyses the conversion of deoxy-uridylate to deoxy-thymidylate and is a key enzyme for DNA synthesis. TS is the target enzyme of 5-fluorouracil (5-FU) and involved in folate metabolism. TS gene polymorphisms play an important role in the efficiency of fluorouracil activity in vivo. This study investigated the allelic frequencies and distribution characters of single-nucleotide polymorphisms within the coding region (cSNPs) of TS gene in Chinese children with acute leukemia (AL) and normal control children in order to explore the possible relationship between the cSNP in human TS gene and chemotherapeutic effects of 5-fluorouracils. METHODS: Bone marrow samples from 53 children with AL and peripheral blood samples from 115 normal children were obtained to prepare complementary DNAs (cDNAs). The cDNAs were analyzed for the polymorphisms in TS gene by reverse transcriptase (RT)-polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis (DGGE) and direct sequencing. The distributive difference of each genotype between AL children and control children was evaluated. RESULTS: A polymorphism 381 A＞G (E127E) in the coding region of TS gene was firstly identified in the Chinese population. The 381 A＞G allelic frequency in AL children and control children was 12.3% and 13.5% respectively (P>0.05), which were similar to that in the International SNP Bank (12.3%). The allelic frequency of cSNPs was not associated with the susceptibility to AL. CONCLUSIONS: A polymorphism 381 A＞G (E127E) in TS gene was successfully identified in children using RT-PCR-DGGE combined with DNA sequencing. There was no significant difference in the allelic frequency of cSNPs in AL children and normal children.［Chin J Contemp Pediatr, 2009, 11 (4):251-254］
胸苷酸合成酶基因 / 编码区单核苷酸多态性 / 变性梯度凝胶电泳 / 急性白血病 / 儿童
Thymidylate synthase gene / Coding single-nucleotide polymorphism / Denaturing gradient gel electrophoresis / Acute leukemia / Children
［1］崔雅静 张健慧. 胸苷酸合成酶(TS)基因多态性及其与肿瘤的关系［J］. 国外医学遗传学分册, 2004, 27（6）：349-353.
［2］Pullarkat ST, Stoehlmacher J, Ghaderi V, Xiong YP, Ingles SA, Sherrod A, et al. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy［J］. Pharmacogenomics J, 2001, 1 (1): 65-70.
［3］Nief N, Le Morvan V, Robert J. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel［J］. Eur J Cancer, 2007, 43 (5): 955-962.
［4］Kuramochi H, Tanaka K, Oh D, Lehman BJ, Dunst CM, Yang DY, et al. Thymidylate synthase polymorphisms and mRNA expression are independent chemotherapy predictive markers in esophageal adenocarcinoma patients［J］. Int J Oncol, 2008, 32(1): 201-208.
［5］Matsui T, Omura K, Kawakami K, Morita S, Sakamoto J. Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer［J］. Oncol Rep, 2006, 16(5):1111-1115.
［6］Marsh S. Thymidylate synthase pharmacogenetics［J］. Invest New Drugs, 2005, 23(6):533-537.
［7］Krajinovic M, Costea I, Primeau M, Dulucq S, Moghrabi A. Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis［J］. Pharmacogenomics J, 2005, 5(6): 374-380.
［8］Danenberg PV. Pharmacogenomics of thymidylate synthase in cancer treatment［J］. Front Biosci, 2004, 9:2484-2494.
［9］Etienne MC, Ilc K, Formento JL, Laurent-Puig P, Formento P, Cheradame S, et al. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity［J］. Br J Cancer, 2004, 90(2): 526-534.
［10］陈小文, 岳丽杰, 李长钢, 张民, 陈运生, 李成荣. 逆转录-PCR-变性梯度凝胶电泳法检测葡萄糖-6-磷酸脱氢酶缺乏症［J］. 中华检验医学杂志, 2007, 30 (9):1048-1051.
［11］陈小文, 岳丽杰, 李成荣, 李长钢, 石红松, 张民. CDA基因多态性与阿糖胞苷敏感性关系的研究［J］.中华血液学杂志, 2008, 29 (7): 459-463.
［12］李长钢，陈小文，陈运生，王缨，赵维玲，石红松，等.运用PCRDGGE技术检测葡萄糖-6-磷酸脱氢酶缺乏的初步研究［J］.中国当代儿科杂志，2007，9（6）：529-532.
［13］杨天楹.急性白血病［M］.//张之南.血液病诊断及疗效标准.第2版.北京：科学出版社，1998，168-214.
［14］van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, Bodmer D, Brüggenwirth H, et al. A DGGE System for comprehentive Mutation Screening of BRCA1 and BRCA2: Application in a Dutch Cancer Clinic Setting［J］. Hum Mutat, 2006, 27 (7): 654-666.
［15］Rendtorff ND, Bjerregaard B, Frodin M, Kjaergaard S, Hove H, Skovby F, et al. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations［J］. Hum Mutat, 2005, 26(4): 374-383.
［16］Lacerra G, Fiorito M, Musollino G, Di Noce F, Esposito M, Nigro V, et al. Sequence variations of the alpha-globin genes: scanning of high CG content genes with DHPLC and DG-DGGE［J］. Hum Mutat, 2004, 24(4): 338-349.
